Annual report pursuant to Section 13 and 15(d)

Business - Revised shareholders' deficiency (Details)

v2.4.0.6
Business - Revised shareholders' deficiency (Details) (USD $)
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net loss for the year $ (7,964,602) $ (5,457,310)
Common Stocks, by Industry [Member]
    
Beginning balance   21,000,000
Effect of reverse merger   46,029,396
Shares issued to consultant   500,000
Shares issued for liquidated damages   13,914
Proceeds from sale of common stock   955,000
Shares issued to extend maturity date of convertible notes payable   112,500
Shares issued upon conversion of convertible note payable   1,018,356
Shares cancelled to consultant   (500,000)
Cancellation of ISR shares   (13,948,000)
Ending balance   55,181,166
CommonStockAmountMember
    
Beginning balance, Value   21,000
Effect of reverse merger, Value   46,029
Shares issued to consultant, Value   500
Shares issued for liquidated damages, Value   14
Proceeds from sale of common stock, Value   955
Shares issued to extend maturity date of convertible notes payable, Value   113
Shares issued upon conversion of convertible note payable, Value   1,018
Shares cancelled to consultant, Value   (500)
Cancellation of ISR shares, Value   (13,948)
Ending balance, Value   55,181
CommonStockAdditionalPaidInCapitalMember
    
Beginning balance, Value   95,967
Effect of reverse merger, Value   1,953,971
Shares issued to consultant, Value   1,949,500
Shares issued for liquidated damages, Value   6,943
Proceeds from sale of common stock, Value   704,045
Shares issued to extend maturity date of convertible notes payable, Value   56,137
Shares issued upon conversion of convertible note payable, Value   508,160
Shares cancelled to consultant, Value   (1,949,500)
Cancellation of ISR shares, Value   13,948
Ending balance, Value   3,339,171
ShareholdersDeficitMember
    
Beginning balance, Value   (706,167)
Net loss for the year   (5,457,310)
Ending balance, Value   (6,163,477)
TotalsMember
    
Beginning balance, Value   (589,200)
Effect of reverse merger, Value   2,000,000
Shares issued to consultant, Value   1,950,000
Shares issued for liquidated damages, Value   6,957
Proceeds from sale of common stock, Value   705,000
Shares issued to extend maturity date of convertible notes payable, Value   56,250
Shares issued upon conversion of convertible note payable, Value   509,178
Shares cancelled to consultant, Value   (1,950,000)
Cancellation of ISR shares, Value     
Net loss for the year   (5,457,310)
Ending balance, Value   $ (2,769,125)